Evidence map›Paper›PMID 34768734›Full record

ArticleInternational journal of molecular sciences2021

Antitumor Activity and Mechanism of Action of Hormonotoxin, an LHRH Analog Conjugated to Dermaseptin-B2, a Multifunctional Antimicrobial Peptide.

Mickael Couty, Marie Dusaud, Mickael Miro-Padovani, Liuhui Zhang, Patricia Zadigue, Loussiné Zargarian, Olivier Lequin, Alexandre de la Taille, Jean Delbe, Yamina Hamma-Kourbali and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Mickael CoutyINSERM, Institut Mondor de Recherche Biomédicale, Université Paris Est Créteil, F-94010 Créteil, France.ORCID 0000-0003-0994-5900
Marie DusaudINSERM, Institut Mondor de Recherche Biomédicale, Université Paris Est Créteil, F-94010 Créteil, France.
Mickael Miro-PadovaniINSERM, Institut Mondor de Recherche Biomédicale, Université Paris Est Créteil, F-94010 Créteil, France.
Liuhui ZhangINSERM, Institut Mondor de Recherche Biomédicale, Université Paris Est Créteil, F-94010 Créteil, France.
Patricia ZadigueINSERM, Institut Mondor de Recherche Biomédicale, Université Paris Est Créteil, F-94010 Créteil, France.
Loussiné ZargarianLBPA, CNRS UMR 8113 École Normale Supérieure Paris-Saclay, 4 Avenue des Sciences, 91190 Gif-sur-Yvette, France.
Olivier LequinSorbonne Université, École Normale Supérieure, PSL University, CNRS, Laboratoire des Biomolécules (LBM), 75005 Paris, France.ORCID 0000-0001-5307-3068
Alexandre de la TailleINSERM, Institut Mondor de Recherche Biomédicale, Université Paris Est Créteil, F-94010 Créteil, France.
Jean DelbeINSERM, Institut Mondor de Recherche Biomédicale, Université Paris Est Créteil, F-94010 Créteil, France.ORCID 0000-0001-6504-0159
Yamina Hamma-KourbaliINSERM, Institut Mondor de Recherche Biomédicale, Université Paris Est Créteil, F-94010 Créteil, France.
Mohamed AmicheINSERM, Institut Mondor de Recherche Biomédicale, Université Paris Est Créteil, F-94010 Créteil, France.ORCID 0000-0001-9811-0635
Inserm · FRCentre National de la Recherche Scientifique · FRÉcole Normale Supérieure Paris-Saclay · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer is the most common cancer in men. For patients with advanced or metastatic prostate cancer, available treatments can slow down its progression but cannot cure it. The development of innovative drugs resulting from the exploration of biodiversity could open new therapeutic alternatives. Dermaseptin-B2, a natural multifunctional antimicrobial peptide isolated from Amazonian frog skin, has been reported to possess antitumor activity. To improve its pharmacological properties and to decrease its peripheral toxicity and lethality we developed a hormonotoxin molecule composed of dermaseptin-B2 combined with d-Lys

Indexed as

Amino Acid SequenceAmphibian ProteinsAnimalsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesAntineoplastic AgentsApoptosisCell Line, TumorCell MovementCell SurvivalGonadotropin-Releasing HormoneHumansImmunologic FactorsMiceMice, NudeAmphibian ProteinsAnti-Bacterial AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesAntineoplastic Agentsdermaseptindermaseptin B2, Phyllomedusa bicolorGonadotropin-Releasing HormoneImmunologic Factorsanticancer drugantimicrobial peptide (AMP)dermaseptinfrog skin peptidesLHRHPhyllomedusa bicolorprostate cancertherapeutic peptides

Identifiers

PMID34768734
PMCPMC8582938
OpenAlexW3187216946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.